Diabetes Week articles from July 2002

Diabetes Week archives from July 2002

Early detection of pancreatic cancer in diabetic patients difficult.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, staff medical writer - Endoscopic retrograde pancreatography (ERP) detected pancreatic carcinoma in high-risk diabetic patients, but the condition was advanced, indicating...

Pulse oximetric method superior to ankle Doppler pressure in screening for peripheral arterial disease.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Investigators in Sweden report that a pulse oximetric toe pressure method demonstrated superior ability over ankle Doppler pressure measurements to...

New method developed for blindness prevention.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- Australian research has led to clinical trials of a drug that could provide a painless and nondestructive way to treat blindness in diabetics. The University of Melbourne-led preclinical research...

University of Maryland Medical Center performs its first islet cell transplant.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- The University of Maryland Medical Center in Baltimore has performed its first islet cell transplant to treat type 1 diabetes, making the center one of only a handful of facilities in the country to...

Rosiglitazone improves glycemic control for Mexicans on metformin.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Adding rosiglitazone to the medication regimen of type 2 diabetic Mexicans receiving only metformin improved glycemic control, researchers in Mexico...

Diabetes Weekly, March 11, 2002.(glargine)(Correction Notice)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- It was brought to the attention of NewsRx that statements in the article "Insulin: Early results show promise for synthetic insulin" may have caused confusion. The Editors would like to clarify that...

Clinical progress reported with neuropathy pain product.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- EpiCept Corporation, a specialty pharmaceutical company focusing on innovative pain relief therapies, announced the progress of clinical trials for the treatment of neuropathic pain in the U.S. and...

L.A.M. signs distribution agreement for wound gel in Mexico.(LAM Pharmaceutical Corp.)(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- LAM Pharmaceutical, Corp. (LAMP; LAM), has appointed Industria Farmaceutica Andromaco S.A. de C.V. as the exclusive distributor of its patented L.A.M. IPM Wound Gel in Mexico. In addition, in...

Agreement reached for use of needle-free delivery device.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR), based in Exton, Pennsylvania, and JCR Pharmaceuticals Co., Ltd., of Ashiya, Japan, announced that JCR has exercised its option under an existing agreement with Antares...

Vardenafil studies report positive results in improved erectile function.
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- At the American Urological Association (AUA) Annual Meeting, physicians presented clinical trial data on the efficacy of vardenafil, an investigational drug under review for the treatment of erectile...

Viagra in black men is effective and well tolerated.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- In the first study to evaluate the efficacy and safety of Viagra (sildenafil citrate) in black men with erectile dysfunction (ED), approximately 8 out of 10 patients reported improvement in their...

Vacuum pressure device helps diabetics.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A device that uses vacuum pressure to increase blood flow to the clitoris and vagina was successful in addressing arousal aspects for diabetics with female sexual...

FDA clears Bayer blood glucose meters for alternate site testing.(Bayer Diagnostics Div.)(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration recently granted Bayer Diagnostics alternate site testing (AST) clearance for its product line of blood glucose self-test monitors. Bayer Diagnostics is the...

Diabetes drugs may help MS sufferers.(multiple sclerosis)(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- Drugs currently used to treat type 2 diabetes may also prove useful for treatment of multiple sclerosis, according to studies at the University of Illinois at Chicago and the West Side Veterans...

Pre-eclampsia linked with higher risk of preterm delivery.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- Every 6 minutes, a woman dies of pre-eclampsia - nine women an hour, according to the Pre-eclampsia Foundation. The disorder, which is linked to hypertension and affects 3 million women a year...

Emerging diabetes epidemic triggers national call for screening.(Brief Article)
July 1, 2002... 2002 JUL 1 - (NewsRx.com & NewsRx.net) -- The alarming increase in the number of overweight and obese children in the United States is generating a new threat - type 2 diabetes. Typically found in adults, type 2 is becoming more prevalent in...

Stent placement better for diabetic patients than angioplasty.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Placement of a stent for treatment of coronary disease is superior to balloon angioplasty in diabetic patients, say Philadelphia, Pennsylvania,...

Retinal thickness strong predictor of macular edema in diabetic patients.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A foveal thickness greater than 180 [micro sign]m may herald macular thickening in diabetic patients and should lead to close follow-up monitoring,...

Diabetes patients fall short of recommended care.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer ? Researchers in the U.S. find a large percentage of diabetes patients face health risks because they lack the recommended routine care and monitoring....

Early treatment of diabetic complications offers lasting benefits.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Intensive intervention to prevent the microvascular complications of type 1 diabetes, if begun early, positively impacts health well into the future....

Whole grain diet improves insulin sensitivity.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A study reported in the American Journal of Clinical Nutrition suggests that eating whole grain food lowers the risk of diabetes through a mechanism...

Islet transplantation doesn't always work.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - In diabetic patients who undergo islet transplantation, episodes of hypoglycemia fail to stimulate glucagon release and counter regulation of hypoglycemia. This...

Medinox initiates phase I trial of NOX-700.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- Medinox, Inc., announced the start of a phase I clinical trial of NOX-700, an orally active nitric oxide (NO) blocking agent in development for diabetes mellitus. The trial is being conducted in the...

Best practices for preventing diabetes-related foot problems.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Diabetes-related foot problems represent a significant burden for primary care physicians. Approximately 90% of the 17 million diabetic patients in the U.S. are...

Company reports first quarter net loss of $0.24 per share.(Amylin Pharmaceuticals Inc.)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported a net loss of $22.1 million, or $0.30 per share, for the first quarter ended March 31, 2002, compared with a net loss of $15.0 million, or $0.24 per share,...

Insulin delivery by pump yields better results than insulin shots.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Results from three studies presented at the American Diabetes Association's 62nd Annual Scientific Sessions in San Francisco, California, demonstrate that, for...

FDA clears two test meters.(TheraSense Inc.'s FreeStyle Tracker Diabetes Managment System and Roche Diagnostics Corp.'s Accu-Check Advantage Module will be able to be used with personal digital assistants)(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has cleared for marketing two glucose test meters used with personal digital assistants (PDAs). The devices will allow people with diabetes to more easily...

Erectile dysfunction is a predictor of ischemic heart disease.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Erectile dysfunction is a strong indicator of future forms of ischemic heart disease, according to a study conducted by Francesco Montorsi, MD, at the University...

Clinicians should consider influenza A and B when diagnosing a febrile respiratory illness during the summer.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- The 2001-02 influenza season was mild to moderate in the United States, according to the U.S. Centers for Disease Control and Prevention. Influenza A (H3N2) viruses predominated, but influenza B...

Artificial pancreas is one step closer to reality.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - An artificial pancreas has long been considered the Holy Grail of diabetes management, yet many patients and their physicians believe that it is decades away....

Oral insulin candidate looks promising in early studies.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Insulin delivery has always been a challenge for patients who struggle with painful injections every day. Of the more than 17 million Americans who have...

ALR Technologies signs agreement with Macromed.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- ALR Technologies, Inc., (ALRT) has signed a business agreement with Macromed, a medical industry consulting/service company based in New York. Macromed provides consulting services to many of the...

Matria agrees to acquire MarketRing.(Matria Healthcare Inc.; MarketRing.com)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- Matria Healthcare, Inc., (MATR) announced the signing of a definitive agreement to acquire MarketRing.com, an Atlanta-based healthcare information technology company. The acquisition of MarketRing...

Older patients are affected by insulin resistance syndrome based on fat distribution.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Insulin resistance syndrome is predicted in the elderly not by increasing age but by obesity and inactivity and possibly a change in the anabolic hormone milieu,...

International survey reveals diabetics are not worried about long-term complications.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A large percentage of people with diabetes are not worried about the long-term microvascular complications associated with the disease, such as blindness or loss...

Alarming increase in children with type 2 diabetes is a wake-up call.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - The number of children who are developing a type of diabetes that normally occurs only in adults is accelerating at an alarming pace. And the results of this new...

Patients at high risk should be screened to help prevent onset of disease.(pre-diabetes screening)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - The term "pre-diabetes" has been officially adopted by the American Diabetes Association and the National Institutes of Diabetes, Digestive and Kidney Diseases...

ADA takes positive position on therapeutic cloning, rejects reproductive cloning.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - The American Diabetes Association during its 62nd Annual Scientific Sessions in San Francisco, California, called upon the U.S. Senate to consider and pass the...

Medifast revenues up by more than 45% YTD in May.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- The Medifast, Inc., (MDFT) annual meeting of shareholders was held on June 6, 2002. At the meeting, Bradley T. MacDonald, chairman and CEO, reported that, "For 5 months, Medifast increased its sales...

Americans getting obese earlier, ethnic groups put on weight at different rates.
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- Overall, 26% of U.S. men and 28% of U.S. women already are obese by about age 36, according to a new University of North Carolina (UNC) at Chapel Hill study of adult weight gain among different ethnic...

Insulin sensitizer has anti-inflammatory effect in diabetics.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- A drug used widely as an insulin sensitizer appears also to have a significant anti-inflammatory effect in diabetics, a property that could make it useful in helping to prevent heart disease in these...

Pill shows promise in preventing diabetes, study says.(Brief Article)
July 8, 2002... 2002 JUL 8 - (NewsRx.com & NewsRx.net) -- A pill that blocks the digestion of starch could prevent or delay the development of the most common form of diabetes in those with slightly high blood sugar, a new study indicates. Experts...

C-reactive protein a potent predictor of type 2 diabetes development.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - C-reactive protein level was a strong predictor of diabetes development for men in the large West of Scotland Coronary Prevention Study. ...

Insulin-like growth factor hinders development of glucose intolerance.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Insulin-like growth factor-I appears to play a role in the prevention of glucose intolerance, according to scientists in the U.K. "Results of...

OHSU researchers develop monkey stem cells that could lead to diabetes treatment.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Researchers at Oregon Health & Science University have developed embryonic stem cells from monkeys that produce and release insulin. They hope this discovery will lead to the development of a monkey...

Swedish researchers report genes related to early onset diabetes.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Researchers at Malmo University Hospital in Sweden have discovered several genes likely to contribute to the development of early onset diabetes. ...

Association between obesity and type 2 diabetes absent in Ugandan men.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Researchers in the U.S. noted that unlike the strong correlation between type 2 diabetes and obesity in developed countries, the two conditions were...

Data reveals Lilly's PKC (beta) inhibitor improved symptoms.(protein kinase C)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Eli Lilly's (LLY) investigational protein kinase C (beta) (PKC (beta)) Inhibitor - also known as LY333531 - improved symptoms, vibratory sensation and other measures of diabetic peripheral neuropathy...

Detection of glucose intolerance could identify patients at high risk of further cardiovascular disease.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- A Swedish study in the June 22, 2002, issue of the Lancet confirms that people admitted to the hospital with an acute heart attack are at an increased risk of having undiagnosed diabetes or increased...

Physicians rank diabetes as higher risk than smoking.(for cardiovascular disease)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Physicians believe that having diabetes is the highest risk factor for cardiovascular disease (CVD) - ranking diabetes higher than smoking, high blood pressure, elevated cholesterol or obesity,...

Additional phase I/II results show continued safety of NBI-6024 in adolescents.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Neurocrine Biosciences, Inc., (NBIX) announced that all doses of NBI-6024 were well tolerated when administered subcutaneously in adolescent patients with type I diabetes, at the 62nd annual meeting of...

Triamcinolone injections improve macular edema when laser photocoagulation fails.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Diabetic patients whose macular edema was not successfully treated with laser photocoagulation showed improvement after intravitreal triamcinolone...

Invivodata electronic diary solution selected for diabetes study.(in Symlin clinical trial)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- invivodata, inc., announced that the invivosystem is being used by Amylin Pharmaceuticals in its current study of Symlin (pramlintide acetate) in people with type 1 diabetes. The 250 patients being...

Wyeth discontinues clinical program for its type-2 diabetes candidate.(PTP-112 clinical trials discontinued)(Brief Article)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Wyeth (WYE) announced that it is discontinuing clinical development of PTP-112. The decision was based on unsatisfactory phase II clinical efficacy, as well as the occurrence of dose-limiting side...

Acadia applies chemical genomics to discover small molecule leads.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals announced the successful application of its proprietary chemical-genomics approach to more than 100 G-protein coupled receptor (GPCR) and nuclear receptor targets. The...

American Diabetes Association forms first diabetes research collaborative.(with Entelos Inc. and Johnson and Johnson Pharmaceutical Research and Development L.L.C.)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- The American Diabetes Association and biotechnology firm Entelos, Inc., announced that the first participant in the Diabetes Research Forum will be Johnson & Johnson Pharmaceutical Research &...

Uncle Sam Cereal meets Glycemic Research Institute criteria.(as a low glycemic food)(Brief Article)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- The Glycemic Research Institute in Washington, DC, announced that Uncle Sam Cereal, a product of Massachusetts based U.S. Mills, Inc., has been approved as low glycemic. The Seal of Approval from...

Trial data show Indiplon (NBI-34060) to be effective sleep aid.
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Neurocrine Biosciences, Inc., (NBIX) presented data from two phase I pharmacokinetic (PK) clinical trials with indiplon (NBI-34060) at the 16th annual meeting of Associated Professional Sleep Societies...

Phase II study results presented at American Diabetes Association meeting.(AeroGen Inc.'s study of AeroDose insulin inhaler)(Brief Article)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Aerogen, Inc., (AEGN) announced that results of its phase II study in type 2 diabetic patients using the company's Aerodose insulin inhaler were presented at the American Diabetes Association 62nd...

SpectRx, Inc., unveils SimpleChoice easy insulin infusion set at ADA meeting.(Brief Article)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- SpectRx, Inc., (SPRX) unveiled its SimpleChoice easy disposable infusion set at the American Diabetes Association meeting in San Francisco. The SimpleChoice easy was the only alternative insulin pump...

Women with ovary disease may also have high risk for heart disease.(polycystic ovarian disease)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Women with polycystic ovaries, a common gynecologic disorder, develop stiff arteries that may increase their risk of heart disease and stroke, according to a report in Circulation: Journal of the...

Alcohol not likely to offer protection.(from the development of type 2 diabetes)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Alcohol is unlikely to protect drinkers from the risk of developing type 2 diabetes, concludes research in the Journal of Epidemiology and Community Health. Alcohol seems to confer only a slight...

Risk of development reduced in acarbose clinical trial.(type 2 diabetes development)
July 15, 2002... 2002 JUL 15 - (NewsRx.com & NewsRx.net) -- Results from the Study to Prevent Non-Insulin Dependent Diabetes Mellitus (STOP-NIDDM), demonstrated that the use of acarbose (Precose, acarbose tablets) reduced the risk of developing type 2 diabetes...

Hyperbaric oxygen therapy improves outcomes for diabetic foot ulcers.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Hyperbaric oxygen (HBO) therapy to treat diabetic foot ulcers increased healing rate and lowered amputation rate according to a report from Sweden....

Microvascular abnormalities of diabetes may start in childhood.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Computer-assisted intravitreal microscopy (CAIM) revealed that microvascular abnormalities might already be present in diabetic children before...

HMG-CoA reductase inhibitor, simvastatin, slows diabetic retinopathy.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A representative HMG-CoA reductase inhibitor, simvastatin, slowed the course of diabetic retinopathy (DR), a complication associated with...

Somatostatin vasoconstriction not caused by insulin inhibition.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Although insulin exerts a vasodilation effect, its removal does not contribute to the renal vasoconstriction effects of somatostatin, according to...

High-carbohydrate, low glycemic index diet improves blood sugar control.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A diet high in carbohydrates that have a low glycemic index was best for managing beta-cell function in people with impaired glucose tolerance,...

Early intervention stops damage to insulin-producing cells in women.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Giving an antidiabetes drug early to women at high risk for type 2 diabetes preserves the health of their insulin-producing cells better than postponing treatment until they actually develop the...

Aging population spurs growth in advanced moist wound dressing markets.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- As the U.S. population ages, demand will continue to rise for advanced dressings used to treat chronic wounds, such as pressure ulcers, venous stasis ulcers, and diabetic ulcers. Moist wound...

Diet high in dairy products reduces risk of insulin resistance.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Overweight adults who consume dairy products were less likely to be insulin resistant and may lower their risk of type 2 diabetes and cardiovascular...

Ascensia to be launched as new brand identity for diabetes franchise.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Bayer Diagnostics announced the upcoming launch of Ascensia as the new global brand identity for its Glucometer diabetes franchise that facilitates day-to-day diabetes management. Under the...

Study: Diabetes self management powerfully affected by healthcare system organizational factors.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Diabetes is a disorder requiring much self-management by patients, and the organization of the healthcare system has a great effect on how patients manage the condition, according to research presented...

Gamma-linoleic acid and ascorbate improve bone formation in fetuses of diabetic rats.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The offspring of pregnant diabetic rats fed gamma-linoleic acid and/or ascorbate showed better bone formation than those whose mothers did not...

Aerogen announces positive phase II study results using the Aerodose insulin inhaler.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Aerogen, Inc., (AEGN) presented positive data from a second phase II study, indicating that type 2 diabetic patients will be able to control their glucose levels with insulin as effectively with the...

Potential blockbusters may be produced by 2006.(Aventis outlines product development plans)
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- At its annual R&D Day, Aventis reaffirmed its intention to more than double the number of blockbusters in its portfolio by 2006 and expressed its confidence in achieving sustainable growth as a result...

Effects of KRX-101 in diabetic kidney disease reported.(results of sulodexide trial)
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Keryx Biopharmaceuticals, Inc., (KERX) announced the publication of an article in the June 2002 edition of the Journal of the American Society of Nephrology, which showed the results of a phase II...

Heart function is decreased in obese young women compared with lean women.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- New research being presented at the American Society of Echocardiography 13th annual Scientific Sessions indicates that obesity in young women is associated with a mild but significant decrease in...

Third quarter net loss: $0.14 per share.(Generex Biotechnology Corp.)
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corporation (GNBT), a leader in the area of buccal drug delivery, announced financial results for its third quarter and 9 months ended April 30, 2002. The company reported a...

Actos effective in people with type 2 diabetes who use insulin.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- People with type 2 diabetes who are unable to adequately manage their blood glucose levels with insulin alone exhibited improved results when Actos (pioglitazone HCl) was added to their treatment...

Amylin Pharmaceuticals provides expanded analyses of AC2993.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) presented expanded analyses from two phase II studies of AC2993 (synthetic exendin-4) in type 2 diabetes. The data were presented during an oral presentation...

Starlix improves glucose in people with prediabetes.
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Starlix (nateglinide) enhances early insulin secretion and controls mealtime glucose spikes in people with impaired glucose tolerance (IGT), a condition also known as prediabetes. These data were...

POSATIV study gives new hope to South Asians with high blood pressure.(Patients Of South Asian Descent Treated with Valsartan)
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- The first U.K. study to examine the effect of modern antihypertensive medication in Southern Asians has been published in the British Journal of Cardiology. The POSATIV (Patients Of South Asian...

Novo Nordisk: Studies demonstrate patient preference for its devices.(Brief Article)
July 22, 2002... 2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Data from patients in three separate studies presented at the 62nd annual Scientific Sessions of the American Diabetes Association have shown marked preferences for insulin delivery systems developed...